Structure

Physi-Chem Properties

Molecular Weight:  510.32
Volume:  529.587
LogP:  3.805
LogD:  2.971
LogS:  -4.158
# Rotatable Bonds:  9
TPSA:  114.68
# H-Bond Aceptor:  8
# H-Bond Donor:  3
# Rings:  3
# Heavy Atoms:  8

MedChem Properties

QED Drug-Likeness Score:  0.189
Synthetic Accessibility Score:  5.242
Fsp3:  0.821
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  1
Golden Triangle Rule:  Rejected
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -4.916
MDCK Permeability:  1.5718173017376103e-05
Pgp-inhibitor:  0.998
Pgp-substrate:  0.907
Human Intestinal Absorption (HIA):  0.093
20% Bioavailability (F20%):  0.007
30% Bioavailability (F30%):  0.09

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.02
Plasma Protein Binding (PPB):  93.64640045166016%
Volume Distribution (VD):  2.096
Pgp-substrate:  6.975322246551514%

ADMET: Metabolism

CYP1A2-inhibitor:  0.015
CYP1A2-substrate:  0.42
CYP2C19-inhibitor:  0.016
CYP2C19-substrate:  0.85
CYP2C9-inhibitor:  0.105
CYP2C9-substrate:  0.15
CYP2D6-inhibitor:  0.025
CYP2D6-substrate:  0.156
CYP3A4-inhibitor:  0.618
CYP3A4-substrate:  0.316

ADMET: Excretion

Clearance (CL):  1.65
Half-life (T1/2):  0.297

ADMET: Toxicity

hERG Blockers:  0.118
Human Hepatotoxicity (H-HT):  0.368
Drug-inuced Liver Injury (DILI):  0.235
AMES Toxicity:  0.479
Rat Oral Acute Toxicity:  0.193
Maximum Recommended Daily Dose:  0.082
Skin Sensitization:  0.353
Carcinogencity:  0.29
Eye Corrosion:  0.131
Eye Irritation:  0.037
Respiratory Toxicity:  0.969

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC280991

Natural Product ID:  NPC280991
Common Name*:   7Alpha-Hydroperoxylabda-8,14-Dien-13(R)-Ol-4-O-Acetyl-Alpha-L-6-Deoxyidopyranoside
IUPAC Name:   [(2S,3S,4R,5R,6S)-6-[(3R)-5-[(3R,4aS,8aS)-3-hydroperoxy-2,5,5,8a-tetramethyl-3,4,4a,6,7,8-hexahydronaphthalen-1-yl]-3-methylpent-1-en-3-yl]oxy-4,5-dihydroxy-2-methyloxan-3-yl] acetate
Synonyms:  
Standard InCHIKey:  CYFQGASFWKNUEE-PEJODWCSSA-N
Standard InCHI:  InChI=1S/C28H46O8/c1-9-27(7,35-25-23(31)22(30)24(17(3)33-25)34-18(4)29)14-11-19-16(2)20(36-32)15-21-26(5,6)12-10-13-28(19,21)8/h9,17,20-25,30-32H,1,10-15H2,2-8H3/t17-,20+,21-,22+,23+,24+,25-,27-,28+/m0/s1
SMILES:  OO[C@@H]1C[C@H]2C(C)(C)CCC[C@@]2(C(=C1C)CC[C@@](O[C@@H]1O[C@@H](C)[C@H]([C@@H]([C@H]1O)O)OC(=O)C)(C=C)C)C
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL483433
PubChem CID:   11049491
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000012] Lipids and lipid-like molecules
      • [CHEMONTID:0000259] Prenol lipids
        • [CHEMONTID:0001551] Diterpenoids

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO16949 Aster oharai Species Asteraceae Eukaryota n.a. n.a. n.a. PMID[12193011]
NPO16949 Aster oharai Species Asteraceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT390 Cell Line LOX IMVI Homo sapiens ED50 > 10.0 ug ml-1 PMID[478594]
NPT147 Cell Line SK-MEL-2 Homo sapiens ED50 > 10.0 ug ml-1 PMID[478594]
NPT383 Cell Line SNB-19 Homo sapiens ED50 > 10.0 ug ml-1 PMID[478594]
NPT380 Cell Line U-251 Homo sapiens ED50 > 10.0 ug ml-1 PMID[478594]
NPT323 Cell Line SW-620 Homo sapiens ED50 > 10.0 ug ml-1 PMID[478594]
NPT148 Cell Line HCT-15 Homo sapiens ED50 > 10.0 ug ml-1 PMID[478594]
NPT81 Cell Line A549 Homo sapiens ED50 > 10.0 ug ml-1 PMID[478594]
NPT146 Cell Line SK-OV-3 Homo sapiens ED50 > 10.0 ug ml-1 PMID[478594]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC280991 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9468 High Similarity NPC91197
0.9468 High Similarity NPC309503
0.9468 High Similarity NPC239547
0.9468 High Similarity NPC155319
0.9468 High Similarity NPC96597
0.9468 High Similarity NPC125551
0.9043 High Similarity NPC67398
0.9043 High Similarity NPC91654
0.9043 High Similarity NPC474792
0.8842 High Similarity NPC474835
0.8812 High Similarity NPC470767
0.8812 High Similarity NPC470763
0.875 High Similarity NPC178949
0.875 High Similarity NPC96736
0.8737 High Similarity NPC302584
0.8725 High Similarity NPC472390
0.8713 High Similarity NPC470768
0.87 High Similarity NPC470571
0.8667 High Similarity NPC473125
0.8641 High Similarity NPC135015
0.8641 High Similarity NPC48548
0.8641 High Similarity NPC128795
0.8641 High Similarity NPC217921
0.8586 High Similarity NPC477928
0.8585 High Similarity NPC473159
0.8585 High Similarity NPC44298
0.8585 High Similarity NPC40133
0.8585 High Similarity NPC290608
0.8585 High Similarity NPC49413
0.8585 High Similarity NPC473128
0.8571 High Similarity NPC90583
0.8558 High Similarity NPC316974
0.8558 High Similarity NPC40728
0.8557 High Similarity NPC211238
0.8544 High Similarity NPC125423
0.8544 High Similarity NPC33053
0.8544 High Similarity NPC88013
0.8485 Intermediate Similarity NPC240372
0.8476 Intermediate Similarity NPC83005
0.8469 Intermediate Similarity NPC286612
0.8469 Intermediate Similarity NPC275310
0.8469 Intermediate Similarity NPC230347
0.8462 Intermediate Similarity NPC311223
0.8447 Intermediate Similarity NPC239961
0.8447 Intermediate Similarity NPC82251
0.8438 Intermediate Similarity NPC261990
0.8438 Intermediate Similarity NPC474249
0.8438 Intermediate Similarity NPC202886
0.8431 Intermediate Similarity NPC127933
0.8431 Intermediate Similarity NPC473123
0.8431 Intermediate Similarity NPC7644
0.8431 Intermediate Similarity NPC473124
0.8431 Intermediate Similarity NPC7613
0.8431 Intermediate Similarity NPC475889
0.8421 Intermediate Similarity NPC248312
0.8416 Intermediate Similarity NPC285231
0.8416 Intermediate Similarity NPC154127
0.8416 Intermediate Similarity NPC21568
0.8416 Intermediate Similarity NPC198992
0.8411 Intermediate Similarity NPC75167
0.8411 Intermediate Similarity NPC470027
0.8411 Intermediate Similarity NPC311592
0.8396 Intermediate Similarity NPC470026
0.8387 Intermediate Similarity NPC166279
0.8367 Intermediate Similarity NPC305160
0.835 Intermediate Similarity NPC201880
0.835 Intermediate Similarity NPC473207
0.835 Intermediate Similarity NPC81567
0.835 Intermediate Similarity NPC203354
0.835 Intermediate Similarity NPC173583
0.835 Intermediate Similarity NPC264867
0.835 Intermediate Similarity NPC110656
0.835 Intermediate Similarity NPC470321
0.835 Intermediate Similarity NPC93352
0.835 Intermediate Similarity NPC473127
0.8349 Intermediate Similarity NPC203862
0.8333 Intermediate Similarity NPC181145
0.8333 Intermediate Similarity NPC477748
0.8333 Intermediate Similarity NPC121423
0.8333 Intermediate Similarity NPC238397
0.8333 Intermediate Similarity NPC154452
0.8333 Intermediate Similarity NPC309310
0.8333 Intermediate Similarity NPC471363
0.8318 Intermediate Similarity NPC328074
0.8318 Intermediate Similarity NPC321272
0.8318 Intermediate Similarity NPC317460
0.8318 Intermediate Similarity NPC470025
0.8317 Intermediate Similarity NPC64348
0.8302 Intermediate Similarity NPC316708
0.8302 Intermediate Similarity NPC170974
0.8302 Intermediate Similarity NPC103627
0.8302 Intermediate Similarity NPC119550
0.8302 Intermediate Similarity NPC191439
0.83 Intermediate Similarity NPC98112
0.8286 Intermediate Similarity NPC219900
0.8286 Intermediate Similarity NPC38376
0.8286 Intermediate Similarity NPC224660
0.8286 Intermediate Similarity NPC80210
0.8286 Intermediate Similarity NPC177524
0.8286 Intermediate Similarity NPC392
0.8269 Intermediate Similarity NPC473199
0.8257 Intermediate Similarity NPC199428
0.8257 Intermediate Similarity NPC207637
0.8257 Intermediate Similarity NPC99620
0.8257 Intermediate Similarity NPC5311
0.8257 Intermediate Similarity NPC310341
0.8257 Intermediate Similarity NPC193382
0.8252 Intermediate Similarity NPC134270
0.8252 Intermediate Similarity NPC281378
0.8241 Intermediate Similarity NPC293658
0.8241 Intermediate Similarity NPC474410
0.8235 Intermediate Similarity NPC11974
0.8235 Intermediate Similarity NPC121072
0.8235 Intermediate Similarity NPC477717
0.8235 Intermediate Similarity NPC21064
0.8224 Intermediate Similarity NPC17791
0.8218 Intermediate Similarity NPC312325
0.8208 Intermediate Similarity NPC195116
0.8208 Intermediate Similarity NPC285253
0.8208 Intermediate Similarity NPC473328
0.8208 Intermediate Similarity NPC206618
0.8208 Intermediate Similarity NPC473318
0.8208 Intermediate Similarity NPC221110
0.8208 Intermediate Similarity NPC180459
0.8208 Intermediate Similarity NPC28844
0.82 Intermediate Similarity NPC129569
0.82 Intermediate Similarity NPC171598
0.8198 Intermediate Similarity NPC477071
0.819 Intermediate Similarity NPC184512
0.819 Intermediate Similarity NPC293512
0.819 Intermediate Similarity NPC281939
0.819 Intermediate Similarity NPC109376
0.819 Intermediate Similarity NPC122816
0.8182 Intermediate Similarity NPC87250
0.8182 Intermediate Similarity NPC142066
0.8182 Intermediate Similarity NPC157376
0.8182 Intermediate Similarity NPC471353
0.8182 Intermediate Similarity NPC158344
0.8182 Intermediate Similarity NPC473852
0.8182 Intermediate Similarity NPC309034
0.8182 Intermediate Similarity NPC243196
0.8182 Intermediate Similarity NPC474418
0.8182 Intermediate Similarity NPC473405
0.8182 Intermediate Similarity NPC196429
0.8182 Intermediate Similarity NPC72817
0.8182 Intermediate Similarity NPC244402
0.8182 Intermediate Similarity NPC471351
0.8182 Intermediate Similarity NPC99728
0.8182 Intermediate Similarity NPC50305
0.8182 Intermediate Similarity NPC34390
0.8182 Intermediate Similarity NPC477927
0.8182 Intermediate Similarity NPC471355
0.8182 Intermediate Similarity NPC77319
0.8182 Intermediate Similarity NPC84987
0.8182 Intermediate Similarity NPC93883
0.8182 Intermediate Similarity NPC471354
0.8182 Intermediate Similarity NPC27507
0.8182 Intermediate Similarity NPC152615
0.8173 Intermediate Similarity NPC85593
0.8173 Intermediate Similarity NPC31430
0.8165 Intermediate Similarity NPC69576
0.8165 Intermediate Similarity NPC471633
0.8165 Intermediate Similarity NPC220293
0.8165 Intermediate Similarity NPC84949
0.8165 Intermediate Similarity NPC31354
0.8163 Intermediate Similarity NPC289361
0.8163 Intermediate Similarity NPC477749
0.8155 Intermediate Similarity NPC150463
0.8155 Intermediate Similarity NPC214277
0.8155 Intermediate Similarity NPC201191
0.8148 Intermediate Similarity NPC216595
0.8148 Intermediate Similarity NPC473567
0.8148 Intermediate Similarity NPC231797
0.8148 Intermediate Similarity NPC174836
0.8144 Intermediate Similarity NPC473058
0.8137 Intermediate Similarity NPC477968
0.8137 Intermediate Similarity NPC161527
0.8137 Intermediate Similarity NPC228251
0.8137 Intermediate Similarity NPC477721
0.8137 Intermediate Similarity NPC477716
0.8137 Intermediate Similarity NPC477972
0.8137 Intermediate Similarity NPC219285
0.8137 Intermediate Similarity NPC20113
0.8137 Intermediate Similarity NPC477971
0.8131 Intermediate Similarity NPC177047
0.8131 Intermediate Similarity NPC65155
0.8125 Intermediate Similarity NPC48692
0.8125 Intermediate Similarity NPC135369
0.8119 Intermediate Similarity NPC473244
0.8113 Intermediate Similarity NPC472988
0.8113 Intermediate Similarity NPC38948
0.8113 Intermediate Similarity NPC470024
0.8113 Intermediate Similarity NPC38217
0.8108 Intermediate Similarity NPC218093
0.8108 Intermediate Similarity NPC470515
0.8108 Intermediate Similarity NPC471548
0.8108 Intermediate Similarity NPC45475
0.8108 Intermediate Similarity NPC83287
0.81 Intermediate Similarity NPC472189
0.81 Intermediate Similarity NPC471362

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC280991 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8286 Intermediate Similarity NPD6686 Approved
0.8214 Intermediate Similarity NPD7503 Approved
0.8108 Intermediate Similarity NPD7327 Approved
0.8108 Intermediate Similarity NPD7328 Approved
0.8036 Intermediate Similarity NPD7516 Approved
0.7965 Intermediate Similarity NPD8377 Approved
0.7965 Intermediate Similarity NPD8294 Approved
0.7895 Intermediate Similarity NPD8380 Approved
0.7895 Intermediate Similarity NPD8033 Approved
0.7895 Intermediate Similarity NPD8379 Approved
0.7895 Intermediate Similarity NPD8378 Approved
0.7895 Intermediate Similarity NPD8296 Approved
0.7895 Intermediate Similarity NPD8335 Approved
0.7706 Intermediate Similarity NPD8132 Clinical (unspecified phase)
0.7627 Intermediate Similarity NPD7507 Approved
0.7523 Intermediate Similarity NPD6412 Phase 2
0.7438 Intermediate Similarity NPD7319 Approved
0.7434 Intermediate Similarity NPD8133 Approved
0.7288 Intermediate Similarity NPD8513 Phase 3
0.7288 Intermediate Similarity NPD8516 Approved
0.7288 Intermediate Similarity NPD8517 Approved
0.7288 Intermediate Similarity NPD8515 Approved
0.7241 Intermediate Similarity NPD8295 Clinical (unspecified phase)
0.7232 Intermediate Similarity NPD4061 Clinical (unspecified phase)
0.7222 Intermediate Similarity NPD5344 Discontinued
0.7196 Intermediate Similarity NPD8029 Clinical (unspecified phase)
0.7196 Intermediate Similarity NPD7638 Approved
0.7167 Intermediate Similarity NPD8328 Phase 3
0.7143 Intermediate Similarity NPD5345 Clinical (unspecified phase)
0.713 Intermediate Similarity NPD7639 Approved
0.713 Intermediate Similarity NPD7640 Approved
0.7105 Intermediate Similarity NPD8413 Clinical (unspecified phase)
0.7019 Intermediate Similarity NPD7838 Discovery
0.7019 Intermediate Similarity NPD46 Approved
0.7019 Intermediate Similarity NPD6698 Approved
0.7018 Intermediate Similarity NPD5955 Clinical (unspecified phase)
0.6931 Remote Similarity NPD6400 Clinical (unspecified phase)
0.6881 Remote Similarity NPD4225 Approved
0.6832 Remote Similarity NPD3669 Approved
0.6832 Remote Similarity NPD3670 Clinical (unspecified phase)
0.6818 Remote Similarity NPD6648 Approved
0.6807 Remote Similarity NPD7115 Discovery
0.6803 Remote Similarity NPD6370 Approved
0.68 Remote Similarity NPD7736 Approved
0.6762 Remote Similarity NPD6051 Approved
0.6754 Remote Similarity NPD5954 Clinical (unspecified phase)
0.6752 Remote Similarity NPD6882 Approved
0.672 Remote Similarity NPD8293 Discontinued
0.672 Remote Similarity NPD8074 Phase 3
0.6696 Remote Similarity NPD7632 Discontinued
0.6694 Remote Similarity NPD7492 Approved
0.6667 Remote Similarity NPD6009 Approved
0.664 Remote Similarity NPD6616 Approved
0.6639 Remote Similarity NPD6319 Approved
0.6639 Remote Similarity NPD6054 Approved
0.661 Remote Similarity NPD8297 Approved
0.6598 Remote Similarity NPD1810 Approved
0.6598 Remote Similarity NPD1811 Approved
0.6587 Remote Similarity NPD7078 Approved
0.6585 Remote Similarity NPD6921 Approved
0.6571 Remote Similarity NPD7524 Approved
0.6555 Remote Similarity NPD4632 Approved
0.6504 Remote Similarity NPD6059 Approved
0.6481 Remote Similarity NPD7983 Approved
0.6481 Remote Similarity NPD6411 Approved
0.6481 Remote Similarity NPD7637 Suspended
0.6471 Remote Similarity NPD6053 Discontinued
0.6452 Remote Similarity NPD6015 Approved
0.6452 Remote Similarity NPD6016 Approved
0.6449 Remote Similarity NPD7625 Phase 1
0.6442 Remote Similarity NPD7338 Clinical (unspecified phase)
0.6436 Remote Similarity NPD7645 Phase 2
0.6422 Remote Similarity NPD6399 Phase 3
0.6422 Remote Similarity NPD5779 Approved
0.6422 Remote Similarity NPD5778 Approved
0.641 Remote Similarity NPD6881 Approved
0.641 Remote Similarity NPD6899 Approved
0.64 Remote Similarity NPD5988 Approved
0.6387 Remote Similarity NPD6650 Approved
0.6387 Remote Similarity NPD6649 Approved
0.6379 Remote Similarity NPD7128 Approved
0.6379 Remote Similarity NPD5739 Approved
0.6379 Remote Similarity NPD6402 Approved
0.6379 Remote Similarity NPD6675 Approved
0.6378 Remote Similarity NPD8451 Approved
0.6373 Remote Similarity NPD7525 Registered
0.6364 Remote Similarity NPD7748 Approved
0.6356 Remote Similarity NPD6373 Approved
0.6356 Remote Similarity NPD6372 Approved
0.6349 Remote Similarity NPD6067 Discontinued
0.6346 Remote Similarity NPD6695 Phase 3
0.6339 Remote Similarity NPD7902 Approved
0.6339 Remote Similarity NPD6084 Phase 2
0.6339 Remote Similarity NPD6083 Phase 2
0.633 Remote Similarity NPD7515 Phase 2
0.6328 Remote Similarity NPD8448 Approved
0.6325 Remote Similarity NPD5697 Approved
0.6308 Remote Similarity NPD8390 Approved
0.6308 Remote Similarity NPD8391 Approved
0.6308 Remote Similarity NPD8392 Approved
0.6303 Remote Similarity NPD6883 Approved
0.6303 Remote Similarity NPD7102 Approved
0.6303 Remote Similarity NPD7290 Approved
0.6303 Remote Similarity NPD6371 Approved
0.6296 Remote Similarity NPD5764 Clinical (unspecified phase)
0.6296 Remote Similarity NPD6101 Approved
0.6289 Remote Similarity NPD2686 Approved
0.6289 Remote Similarity NPD2687 Approved
0.6289 Remote Similarity NPD2254 Approved
0.6273 Remote Similarity NPD8171 Discontinued
0.6271 Remote Similarity NPD7320 Approved
0.626 Remote Similarity NPD7260 Phase 2
0.625 Remote Similarity NPD6869 Approved
0.625 Remote Similarity NPD8130 Phase 1
0.625 Remote Similarity NPD6847 Approved
0.625 Remote Similarity NPD6617 Approved
0.6226 Remote Similarity NPD1694 Approved
0.622 Remote Similarity NPD7829 Approved
0.622 Remote Similarity NPD7604 Phase 2
0.622 Remote Similarity NPD7642 Approved
0.622 Remote Similarity NPD7830 Approved
0.6218 Remote Similarity NPD6013 Approved
0.6218 Remote Similarity NPD6014 Approved
0.6218 Remote Similarity NPD6012 Approved
0.619 Remote Similarity NPD8444 Approved
0.619 Remote Similarity NPD5983 Phase 2
0.6186 Remote Similarity NPD7899 Clinical (unspecified phase)
0.6186 Remote Similarity NPD5701 Approved
0.6174 Remote Similarity NPD4159 Approved
0.6172 Remote Similarity NPD8340 Approved
0.6172 Remote Similarity NPD8299 Approved
0.6172 Remote Similarity NPD8341 Approved
0.6172 Remote Similarity NPD8342 Approved
0.6161 Remote Similarity NPD5695 Phase 3
0.6154 Remote Similarity NPD1780 Approved
0.6154 Remote Similarity NPD1779 Approved
0.6142 Remote Similarity NPD5125 Phase 3
0.6142 Remote Similarity NPD5126 Approved
0.6134 Remote Similarity NPD6011 Approved
0.6124 Remote Similarity NPD6336 Discontinued
0.6122 Remote Similarity NPD7532 Clinical (unspecified phase)
0.6111 Remote Similarity NPD7750 Discontinued
0.6111 Remote Similarity NPD4751 Clinical (unspecified phase)
0.6106 Remote Similarity NPD7839 Suspended
0.6095 Remote Similarity NPD4752 Clinical (unspecified phase)
0.6091 Remote Similarity NPD3168 Discontinued
0.609 Remote Similarity NPD8449 Approved
0.6071 Remote Similarity NPD7901 Clinical (unspecified phase)
0.6071 Remote Similarity NPD7900 Approved
0.6058 Remote Similarity NPD7332 Phase 2
0.6058 Remote Similarity NPD6931 Approved
0.6058 Remote Similarity NPD6930 Phase 2
0.6058 Remote Similarity NPD7514 Phase 3
0.6045 Remote Similarity NPD8450 Suspended
0.604 Remote Similarity NPD6942 Approved
0.604 Remote Similarity NPD7339 Approved
0.6033 Remote Similarity NPD4634 Approved
0.6031 Remote Similarity NPD6033 Approved
0.6029 Remote Similarity NPD7966 Clinical (unspecified phase)
0.6019 Remote Similarity NPD7521 Approved
0.6019 Remote Similarity NPD6409 Approved
0.6019 Remote Similarity NPD6684 Approved
0.6019 Remote Similarity NPD7334 Approved
0.6019 Remote Similarity NPD7146 Approved
0.6019 Remote Similarity NPD5330 Approved
0.6017 Remote Similarity NPD8170 Clinical (unspecified phase)
0.6 Remote Similarity NPD5696 Approved
0.6 Remote Similarity NPD8137 Clinical (unspecified phase)
0.5984 Remote Similarity NPD6401 Clinical (unspecified phase)
0.5983 Remote Similarity NPD5211 Phase 2
0.5981 Remote Similarity NPD4786 Approved
0.598 Remote Similarity NPD3701 Clinical (unspecified phase)
0.598 Remote Similarity NPD6933 Approved
0.597 Remote Similarity NPD6845 Suspended
0.5966 Remote Similarity NPD6008 Approved
0.5965 Remote Similarity NPD4792 Clinical (unspecified phase)
0.5963 Remote Similarity NPD4251 Approved
0.5963 Remote Similarity NPD4250 Approved
0.5963 Remote Similarity NPD3573 Approved
0.5962 Remote Similarity NPD6929 Approved
0.5952 Remote Similarity NPD7641 Discontinued
0.5948 Remote Similarity NPD5286 Approved
0.5948 Remote Similarity NPD5285 Approved
0.5948 Remote Similarity NPD4696 Approved
0.5946 Remote Similarity NPD8522 Clinical (unspecified phase)
0.5943 Remote Similarity NPD3667 Approved
0.594 Remote Similarity NPD5956 Approved
0.5926 Remote Similarity NPD6082 Clinical (unspecified phase)
0.5922 Remote Similarity NPD6932 Approved
0.5913 Remote Similarity NPD4755 Approved
0.5909 Remote Similarity NPD6903 Approved
0.5909 Remote Similarity NPD6672 Approved
0.5909 Remote Similarity NPD7513 Clinical (unspecified phase)
0.5909 Remote Similarity NPD5737 Approved
0.5906 Remote Similarity NPD7100 Approved
0.5906 Remote Similarity NPD7101 Approved
0.5905 Remote Similarity NPD4820 Approved
0.5905 Remote Similarity NPD5790 Clinical (unspecified phase)
0.5905 Remote Similarity NPD4819 Approved
0.5905 Remote Similarity NPD4822 Approved

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data